Porous graphitic carbon shows promise for the rapid chromatographic analysis of polar drug metabolites.
A rapid and simple HPLC method has been developed and used to separate the polar metabolic conjugates of AZT, chloramphenicol, and beta-estradiol based upon the use of porous graphitic carbon. The HPLC system is sufficiently selective to resolve the polar drug conjugates from their parent compounds and from endogenous material present in urine. The compounds are separated, without the need for sample pretreatment or gradient elution, on a porous graphitic carbon (Hypercarb) column using aqueous trifluoroacetic acid modified with tetrahydrofuran as the mobile phase. Porous graphitic carbon exhibits a novel mechanism of retention towards these very polar substances, which are unretained under reversed-phase conditions on alkyl-bonded silica phases.
Ayrton
J
J
Glaxo Research and Development, Greenford, Middlesex, UK.
Evans
M B
MB
Harris
A J
AJ
Plumb
R S
RS
D000818:Animals; D002701:Chloramphenicol / Q000378:metabolism / Q000652:urine*; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D004285:Dogs; D004958:Estradiol / Q000378:metabolism / Q000652:urine*; D005965:Glucuronates / Q000652:urine*; D006108:Graphite / Q000737:chemistry*; D013056:Spectrophotometry, Ultraviolet; D015215:Zidovudine / Q000378:metabolism / Q000652:urine*
D005965:Glucuronates; D015215:Zidovudine; D004958:Estradiol; D002701:Chloramphenicol; D006108:Graphite